Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
After Jazz, Hikma Agrees $50m Settlement For ‘Most’ Xyrem ‘Pay-For-Delay’ Claims
Trial Was Set To Begin 19 May; Jazz Pharma Agreed Settlement Last Month For $145m
May 08 2025
•
By
Dean Rudge
• Source: Alamy
More from Legal & IP
More from Products